From Our Thought Leader's

Shanghai Junshi Biosciences' sNDA for Toripalimab and Bevacizumab Combo for Advanced Liver Cancer Accepted by NMPA

  Shanghai Junshi Biosciences Co., a leading innovation-driven biopharmaceutical company dedicated to the discovery, development, and commercialization of novel therapies, announced that the National Medical Products Administration (NMPA) has a... Read more

19 July, 2024 | Friday | News
Novartis CEO Vas Narasimhan Announces Impressive Q2 2024 Results: 11% Net Sales Surge and Upgraded FY2024 Guidance

net sales grew +11% (cc1, +9% USD) with core operating income up +19% (cc, +17% USD) Sales growth driven by continued strong performance from Entresto (+28% cc), Kesimpta(+65% cc), Cosentyx (+22% cc), Kisqali (+50% cc), Leqvio (+134% cc) and... Read more

18 July, 2024 | Thursday | Company results
Paul Limburg Highlights Commitment to Reducing Screening Disparities Through the FOCUS Program's Support of 28 Organizations Nationwide

  Exact Sciences, a leading provider of cancer screening and diagnostic tests, announced  that it awarded a total of $1.5 million to 28 organizations through its Funding Opportunities for CRC Screening Uptake Strategies (FOCUS) Program. Gr... Read more

18 July, 2024 | Thursday | News
Boehringer Ingelheim Chairman von Baumbach Highlights Strong H1 2024 Performance and Pipeline Milestones

Milestones reached in cardiovascular, renal, metabolic health (CRM), and oncology Further data read-outs expected in 2024 in oncology, mental health, and pulmonary fibrosis Strong first half net sales growth of 7.4%* year on year Boehringer ... Read more

18 July, 2024 | Thursday | News

Bio Finance

Rona Therapeutics Secures $35 Million Series A+ Financing Led by LongRiver Investments

Rona Therapeutics, a clinical stage pioneering platform company in nucleic acid drug research and development, today announced the completion of $35 Million Series A+ financing. This round was led by LongRiver Investments, with participation from i... Read more

19 July, 2024 | Friday | News
Novartis CEO Vas Narasimhan Announces Impressive Q2 2024 Results: 11% Net Sales Surge and Upgraded FY2024 Guidance

net sales grew +11% (cc1, +9% USD) with core operating income up +19% (cc, +17% USD) Sales growth driven by continued strong performance from Entresto (+28% cc), Kesimpta(+65% cc), Cosentyx (+22% cc), Kisqali (+50% cc), Leqvio (+134% cc) and... Read more

18 July, 2024 | Thursday | Company results

Contract Services

Catalent Expands Flagship European Clinical Supply Facility in Schorndorf, Germany

Catalent, the leader in enabling the development and supply of better treatments for patients worldwide, today announced it has completed expansion of its clinical supply facility in Schorndorf, Germany. The Schorndorf site, Catalent’s flagsh... Read more

17 July, 2024 | Wednesday | News
CordenPharma Announces Record €900M Investment to Expand Peptide Platform in US and Europe

CordenPharma is making a record investment of ~€900m over the next 3 years in expanding its peptide platform, both at its Colorado, US site and in Europe. The expansions, covering both existing facilities and new constructions, will meet the... Read more

16 July, 2024 | Tuesday | News

BioPharma Video

Survey Box

Poll of the Week

Which area of biopharmaceutical research excites you the most?

× Please select an option to participate in the poll.
Processing...
× You have successfully cast your vote.
 {{ optionDetail.option }}  {{ optionDetail.percentage }}%
 {{ optionDetail.percentage }}% Complete
More polls
Stay Connected

Sign up to our free newsletter and get the latest news sent direct to your inbox

© 2024 Biopharma Boardroom. All Rights Reserved.

Show

Forgot your password?

Show

Show

Lost your password? Please enter your email address. You will receive a link to create a new password.

Back to log-in

Close